You are here

  • Home
  • Archive
  • Volume 74, Issue Suppl 2
  • SAT0198 Effect of Increased Sarilumab Dose on Efficacy and Safety Outcomes in Poorly Responding Rheumatoid Arthritis (RA) Patients: The Mobility Study

Article metrics

Article menu
Download PDFPDF
Poster Presentations
Rheumatoid arthritis - other biologic treatment
SAT0198 Effect of Increased Sarilumab Dose on Efficacy and Safety Outcomes in Poorly Responding Rheumatoid Arthritis (RA) Patients: The Mobility Study

 

Online download statistics by month:

Online download statistics by month: June 2015 to March 2024

AbstractFullPdf
Jun 2015901
Jul 2015402
Aug 2015200
Sep 2015901
Oct 2015400
Nov 20151000
Dec 20151103
Jan 20161403
Feb 20161300
Mar 20163608
Apr 20161701
May 2016601
Jun 20161400
Jul 2016901
Aug 2016802
Sep 201615027
Oct 2016901
Nov 2016600
Dec 2016701
Jan 20171400
Feb 20171301
Mar 201718011
Apr 2017600
May 2017801
Jun 2017700
Jul 20171202
Aug 20171200
Sep 2017600
Oct 2017600
Nov 20171000
Dec 2017600
Jan 20181000
Feb 2018802
Mar 20181603
Apr 2018600
May 2018800
Jun 2018600
Jul 20181200
Aug 20181000
Sep 2018200
Oct 2018200
Nov 2018200
Dec 20181200
Jan 2019400
Feb 2019202
Mar 2019300
Apr 2019600
May 20192600
Jul 20191903
Oct 2019200
Nov 2019300
Dec 2019400
Feb 2020400
Mar 2020200
Apr 2020200
Jun 20201000
Jul 2020600
Aug 2020200
Sep 20203300
Oct 2020200
Nov 2020600
Feb 20211000
Mar 2021201
Apr 20211700
Jun 2021500
Jul 2021100
Oct 20211000
Nov 20211200
Dec 20211000
Jan 2022400
Feb 2022400
Mar 20221500
Apr 2022200
May 20221000
Jun 2022200
Jul 20222000
Aug 20221000
Sep 2022800
Oct 20223600
Nov 2022400
Dec 20221400
Jan 2023400
Feb 2023600
Mar 2023400
May 2023400
Jul 2023200
Aug 2023200
Sep 2023400
Oct 2023200
Nov 20232400
Dec 20231000
Jan 2024200
Feb 2024200
Mar 2024400
Total817078